The VEGF Targeted Drugs for Breast Cancer Market is expected to grow at a CAGR of 6% during the forecast period 2022-2028. VEGF-targeting drugs for breast cancer are a class of drugs that block the action of vascular endothelial growth factor (VEGF). VEGF is a protein that promotes the growth of new blood vessels. By […]
